ImmunoMRI for Assessment of Tumor-associated Macrophages
NCT07066436
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
DLBCL - Diffuse Large B Cell Lymphoma
Interventions
DRUG:
MRI contrast-enhancing agents
Sponsor
Medical University of Vienna